According to a recent LinkedIn post from Cleerly, the company is highlighting its presence at the ACC.26 cardiology conference, where several executives and clinical leaders are participating in an onsite meet-and-greet. The post emphasizes the context of a new Category I CPT code and expanded insurance coverage related to its technology, suggesting a shifting reimbursement environment for cardiology imaging and AI-enabled care.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post positions Cleerly as engaging directly with cardiology professionals at Booth #1645 and promoting a schedule of conference activities, which may help deepen relationships with key clinical decision-makers. For investors, the reference to a Category I CPT code and broader coverage could indicate improving pathways to commercialization and revenue, potentially strengthening Cleerly’s competitive standing in AI-driven cardiovascular diagnostics if physician adoption follows.

